Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1989 Jun;44(6):496–500. doi: 10.1136/thx.44.6.496

Malignant pleural mesothelioma in western Glasgow 1980-6.

G Hulks 1, J S Thomas 1, E Waclawski 1
PMCID: PMC1020811  PMID: 2763260

Abstract

This study reviews all histologically proved cases of malignant pleural mesothelioma seen in the western district of Glasgow during 1980-6. Sixty eight cases were identified (three female) with an age range at presentation of 48-85 (mean 68.9) years. Asbestos exposure was identified in 54 (80%) of the patients, most of whom had been shipyard workers. Pain and dyspnoea were the most common presenting symptoms. Pleural effusion was found in 57 (84%) of the patients, in a ratio of 2.6 right:left. The median survival was only 30 weeks from the time of presentation. Prognosis was significantly better for those presenting with dyspnoea than for those with pain (median survival 44 v 22 weeks). Postmortem examination was performed in 40 cases and metastatic disease found in more than three quarters. There was no significant difference between the incidence of the various tumour cell types or any relation between cell type and survival or the incidence of metastatic disease. A substantial increase in cases of malignant pleural mesothelioma has been found in an area of already high incidence. The use of rigorous histological criteria to determine histological cell type has shown that this previously valued variable is of no discriminatory value with regard to disease activity or survival.

Full text

PDF
496

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams V. I., Unni K. K. Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study. Am J Clin Pathol. 1984 Jul;82(1):15–23. doi: 10.1093/ajcp/82.1.15. [DOI] [PubMed] [Google Scholar]
  2. Adams V. I., Unni K. K., Muhm J. R., Jett J. R., Ilstrup D. M., Bernatz P. E. Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer. 1986 Oct 1;58(7):1540–1551. doi: 10.1002/1097-0142(19861001)58:7<1540::aid-cncr2820580727>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  3. Antman K. H., Blum R. H., Greenberger J. S., Flowerdew G., Skarin A. T., Canellos G. P. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med. 1980 Mar;68(3):356–362. doi: 10.1016/0002-9343(80)90103-5. [DOI] [PubMed] [Google Scholar]
  4. Antman K., Shemin R., Ryan L., Klegar K., Osteen R., Herman T., Lederman G., Corson J. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol. 1988 Jan;6(1):147–153. doi: 10.1200/JCO.1988.6.1.147. [DOI] [PubMed] [Google Scholar]
  5. Bindi M., Miracco C., Gotti G., Tucci E., Nardi P., Pirtoli L. Metastatic spread of malignant pleural mesothelioma. Rays. 1985 May-Aug;10(2):131–136. [PubMed] [Google Scholar]
  6. Brenner J., Sordillo P. P., Magill G. B., Golbey R. B. Malignant mesothelioma of the pleura: review of 123 patients. Cancer. 1982 Jun 1;49(11):2431–2435. doi: 10.1002/1097-0142(19820601)49:11<2431::aid-cncr2820491134>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  7. Butchart E. G., Ashcroft T., Barnsley W. C., Holden M. P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976 Feb;31(1):15–24. doi: 10.1136/thx.31.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chahinian A. P., Pajak T. F., Holland J. F., Norton L., Ambinder R. M., Mandel E. M. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med. 1982 Jun;96(6 Pt 1):746–755. doi: 10.7326/0003-4819-96-6-746. [DOI] [PubMed] [Google Scholar]
  9. Chailleux E., Dabouis G., Pioche D., de Lajartre M., de Lajartre A. Y., Rembeaux A., Germaud P. Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. Chest. 1988 Jan;93(1):159–162. doi: 10.1378/chest.93.1.159. [DOI] [PubMed] [Google Scholar]
  10. Churg J., Rosen S. H., Moolten S. Histological characteristics of mesothelioma associated with asbestos. Ann N Y Acad Sci. 1965 Dec 31;132(1):614–622. doi: 10.1111/j.1749-6632.1965.tb41141.x. [DOI] [PubMed] [Google Scholar]
  11. Corson J. M., Pinkus G. S. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol. 1982 Jul;108(1):80–88. [PMC free article] [PubMed] [Google Scholar]
  12. Dorward A. J., Stack B. H. Diffuse malignant pleural mesothelioma in Glasgow. Br J Dis Chest. 1981 Oct;75(4):397–402. doi: 10.1016/0007-0971(81)90027-9. [DOI] [PubMed] [Google Scholar]
  13. Elmes P. C., Simpson J. C. The clinical aspects of mesothelioma. Q J Med. 1976 Jul;45(179):427–449. [PubMed] [Google Scholar]
  14. Greenberg M., Davies T. A. Mesothelioma register 1967-68. Br J Ind Med. 1974 Apr;31(2):91–104. doi: 10.1136/oem.31.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Griffiths M. H., Riddell R. J., Xipell J. M. Malignant mesothelioma: a review of 35 cases with diagnosis and prognosis. Pathology. 1980 Oct;12(4):591–603. doi: 10.3109/00313028009086812. [DOI] [PubMed] [Google Scholar]
  16. HOURIHANE D. O. THE PATHOLOGY OF MESOTHELIOMATA AND AN ANALYSIS OF THEIR ASSOCIATION WITH ASBESTOS EXPOSURE. Thorax. 1964 May;19:268–278. doi: 10.1136/thx.19.3.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harrison R. N. Sarcomatous pleural mesothelioma and cerebral metastases: case report and a review of eight cases. Eur J Respir Dis. 1984 Apr;65(3):185–188. [PubMed] [Google Scholar]
  18. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest. 1983 Oct;77(4):321–343. [PubMed] [Google Scholar]
  19. Huncharek M., Muscat J. Metastases in diffuse pleural mesothelioma: influence of histological type. Thorax. 1987 Nov;42(11):897–898. doi: 10.1136/thx.42.11.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jones B., Thomas P. Incidence of mesothelioma in Britain. Lancet. 1986 May 31;1(8492):1275–1275. doi: 10.1016/s0140-6736(86)91414-5. [DOI] [PubMed] [Google Scholar]
  21. Kannerstein M., Churg J., Magner D. Histochemistry in the diagnosis of malignant mesothelioma. Ann Clin Lab Sci. 1973 May-Jun;3(3):207–211. [PubMed] [Google Scholar]
  22. Krumhaar D., Lange S., Hartmann C., Anhuth D. Follow-up study of 100 malignant pleural mesotheliomas. Thorac Cardiovasc Surg. 1985 Oct;33(5):272–275. doi: 10.1055/s-2007-1014139. [DOI] [PubMed] [Google Scholar]
  23. Law M. R., Gregor A., Hodson M. E., Bloom H. J., Turner-Warwick M. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax. 1984 Apr;39(4):255–259. doi: 10.1136/thx.39.4.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Law M. R., Hodson M. E., Heard B. E. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982 Nov;37(11):810–815. doi: 10.1136/thx.37.11.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Loosli H., Hurlimann J. Immunohistological study of malignant diffuse mesotheliomas of the pleura. Histopathology. 1984 Sep;8(5):793–803. doi: 10.1111/j.1365-2559.1984.tb02395.x. [DOI] [PubMed] [Google Scholar]
  26. Machin T., Mashiyama E. T., Henderson J. A., McCaughey W. T. Bony metastases in desmoplastic pleural mesothelioma. Thorax. 1988 Feb;43(2):155–156. doi: 10.1136/thx.43.2.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McCAUGHEY W. T. Primary tumours of the pleura. J Pathol Bacteriol. 1958 Oct;76(2):517–529. doi: 10.1002/path.1700760222. [DOI] [PubMed] [Google Scholar]
  28. McCaughey W. T. Asbestos and neoplasia: diffuse mesothelial tumors. Criteria for diagnosis of diffuse mesothelial tumors. Ann N Y Acad Sci. 1965 Dec 31;132(1):603–613. doi: 10.1111/j.1749-6632.1965.tb41140.x. [DOI] [PubMed] [Google Scholar]
  29. McCormack P. M., Nagasaki F., Hilaris B. S., Martini N. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg. 1982 Dec;84(6):834–842. [PubMed] [Google Scholar]
  30. Otis C. N., Carter D., Cole S., Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol. 1987 Jun;11(6):445–456. doi: 10.1097/00000478-198706000-00005. [DOI] [PubMed] [Google Scholar]
  31. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pillgram-Larsen J., Urdal L., Smith-Meyer R., Birkeland S. Malignant pleural mesothelioma. A clinical review of 19 patients. Scand J Thorac Cardiovasc Surg. 1984;18(1):69–73. doi: 10.3109/14017438409099387. [DOI] [PubMed] [Google Scholar]
  33. Roberts G. H. Distant visceral metastases in pleural mesothelioma. Br J Dis Chest. 1976 Oct;70(4):246–250. doi: 10.1016/0007-0971(76)90039-5. [DOI] [PubMed] [Google Scholar]
  34. SEMB G. DIFFUSE MALIGNANT PLEURAL MESOTHELIOMA: A CLINICOPATHOLOGICAL STUDY OF 10 FATAL CASES. Acta Chir Scand. 1963 Jul-Aug;126:78–91. [PubMed] [Google Scholar]
  35. Wanebo H. J., Martini N., Melamed M. R., Hilaris B., Beattie E. J., Jr Pleural mesothelioma. Cancer. 1976 Dec;38(6):2481–2488. doi: 10.1002/1097-0142(197612)38:6<2481::aid-cncr2820380637>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  36. Whitwell F., Rawcliffe R. M. Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax. 1971 Jan;26(1):6–22. doi: 10.1136/thx.26.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES